Aesthetic Appeal Add us as a preferred source on Google

What is your medical spa actually worth — and what would it take to sell it for real money? Aesthetic Appeal is the podcast for medical aesthetics practice owners thinking seriously about valuation, growth, profitability, and the exit they actually want. Hosted by Bill Walker, Founder & CEO of Aesthetic Brokers, and Jessica Hunter, Head of Aesthetic Consulting, the show breaks down med spa M&A, private equity deals, EBITDA, pricing, and the operational decisions that quietly add or destroy millions in enterprise value.Every episode answers the questions med spa owners, plastic surgeons, and cosmetic dermatology operators type into Google at midnight: what is my practice worth, when should I sell, how do I raise prices without losing patients, why is my million-dollar practice not profitable, and what does private equity actually want from aesthetic clinics in 2026.Bill brings the deal side. A former Marine Corps pilot turned M&A advisor, he led mergers and acquisitions for a private equity-backed healthcare platform before founding Aesthetic Brokers, helping doctors unlock hundreds of millions of dollars in generational wealth. On the show, he covers valuation math, buyer behavior, deal structure, due diligence, letters of intent, and what investors are actually paying for an aesthetic practice today.Jessica brings the operator side. After consulting with more than 75 medical aesthetic clinics across the U.S. and Canada, she knows exactly what makes a clinic sellable long before a broker is on the phone — provider redundancy, P&L hygiene, time discipline, pricing strategy, and the financial habits owners avoid until it's too late.Recurring topics include medical spa valuations and EBITDA multiples; private equity, MSOs, and platform consolidation in aesthetics; selling a med spa or plastic surgery practice; exit strategy planning for first-time founders; pricing models and raising prices without losing clients; the hidden math behind "million-dollar" practices; GLP-